60 related articles for article (PubMed ID: 34362508)
1. Co-occurrence of
Zanelli M; Bisagni A; Sanguedolce F; Broggi G; Fragliasso V; Zizzo M; Palicelli A; Martino G; Cresta C; Caprera C; Corsi M; Gentile P; Gozzi F; Trombetta D; Parente P; Caltabiano R; Koufopoulos N; Cimino L; Cavazza A; Fraternali Orcioni G; Ascani S
Front Oncol; 2023; 13():1329298. PubMed ID: 38282677
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloproliferative neoplasms with concomitant
Zanelli M; Fragliasso V; Loscocco GG; Sanguedolce F; Broggi G; Zizzo M; Palicelli A; Ricci S; Ambrogi E; Martino G; Aversa S; Coppa F; Gentile P; Gozzi F; Caltabiano R; Koufopoulos N; Asaturova A; Cimino L; Cavazza A; Orcioni GF; Ascani S
Front Cell Dev Biol; 2024; 12():1391078. PubMed ID: 38596359
[TBL] [Abstract][Full Text] [Related]
3. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage.
Suárez EU; Piris MÁ; Rodríguez-Pinilla SM; García JF; López-Lorenzo JL; Cornago-Navascués J; Salgado-Sánchez R; Castaño-Bonilla T; Mata-Serna R; Alonso-Domínguez JM; Llamas P
Ann Hematol; 2024 May; 103(5):1797-1799. PubMed ID: 38308706
[No Abstract] [Full Text] [Related]
4. Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives.
Krecak I; Verstovsek S; Lucijanic M
Ann Hematol; 2024 May; 103(5):1513-1523. PubMed ID: 37665349
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of ETV6-ABL Fusion Gene in Hematopoietic Cell Populations of Myeloproliferative Neoplasm].
Chen Y; Liu Q; Li Y; Wei H; Rao Q; Wang M; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1242-1246. PubMed ID: 34362509
[TBL] [Abstract][Full Text] [Related]
6. The Unfolded Protein Response Is a Major Driver of LCN2 Expression in BCR-ABL- and JAK2V617F-Positive MPN.
Tillmann S; Olschok K; Schröder SK; Bütow M; Baumeister J; Kalmer M; Preußger V; Weinbergerova B; Kricheldorf K; Mayer J; Kubesova B; Racil Z; Wessiepe M; Eschweiler J; Isfort S; Brümmendorf TH; Becker W; Schemionek M; Weiskirchen R; Koschmieder S; Chatain N
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439364
[TBL] [Abstract][Full Text] [Related]
7. The Tyrosine Kinase-Driven Networks of Novel Long Non-coding RNAs and Their Molecular Targets in Myeloproliferative Neoplasms.
Wong NK; Luo S; Chow EYD; Meng F; Adesanya A; Sun J; Ma HMH; Jin W; Li WC; Yip SP; Huang CL
Front Cell Dev Biol; 2021; 9():643043. PubMed ID: 34414175
[TBL] [Abstract][Full Text] [Related]
8. AXL Inhibition Represents a Novel Therapeutic Approach in
Beitzen-Heineke A; Berenbrok N; Waizenegger J; Paesler S; Gensch V; Udonta F; Vargas Delgado ME; Engelmann J; Hoffmann F; Schafhausen P; von Amsberg G; Riecken K; Beumer N; Imbusch CD; Lorens J; Fischer T; Pantel K; Bokemeyer C; Ben-Batalla I; Loges S
Hemasphere; 2021 Sep; 5(9):e630. PubMed ID: 34396051
[No Abstract] [Full Text] [Related]
9. TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis.
Varricchio L; Iancu-Rubin C; Upadhyaya B; Zingariello M; Martelli F; Verachi P; Clementelli C; Denis JF; Rahman AH; Tremblay G; Mascarenhas J; Mesa RA; O'Connor-McCourt M; Migliaccio AR; Hoffman R
JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34383713
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas12a-Based Ultrasensitive and Rapid Detection of
Chen M; Zhang C; Hu Z; Li Z; Li M; Wu L; Zhou M; Liang D
Biosensors (Basel); 2021 Jul; 11(8):. PubMed ID: 34436049
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Loscocco GG; Guglielmelli P; Gangat N; Rossi E; Mannarelli C; Betti S; Maccari C; Ramundo F; Jadoon Y; Gesullo F; Ceglie S; Paoli C; Pardanani A; De Stefano V; Tefferi A; Vannucchi AM
Am J Hematol; 2021 Nov; 96(11):1472-1480. PubMed ID: 34424575
[TBL] [Abstract][Full Text] [Related]
12. Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Dam MJB; Pedersen RK; Knudsen TA; Andersen M; Skov V; Kjaer L; Hasselbalch HC; Ottesen JT
Eur J Haematol; 2021 Dec; 107(6):624-633. PubMed ID: 34411333
[TBL] [Abstract][Full Text] [Related]
13. The requirement for pyruvate dehydrogenase in leukemogenesis depends on cell lineage.
Jun S; Mahesula S; Mathews TP; Martin-Sandoval MS; Zhao Z; Piskounova E; Agathocleous M
Cell Metab; 2021 Sep; 33(9):1777-1792.e8. PubMed ID: 34375613
[TBL] [Abstract][Full Text] [Related]
14. Proposal and clinical application of molecular genetic risk scoring system, "MRplus", for BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia- report from a single centre.
Gupta SK; Bakhshi S; Kamal VK; Gupta R; Sharma P; Pushpam D; Sahoo RK; Sharma A
Leuk Res; 2021 Dec; 111():106683. PubMed ID: 34371436
[TBL] [Abstract][Full Text] [Related]
15. Leukemia associated RUNX1T1 gene reduced proliferation and invasiveness of glioblastoma cells.
Kumar P; Verma V; Mohania D; Gupta S; Babbar AK; Rathi B; Dhanda RS; Yadav M
J Cell Biochem; 2021 Nov; 122(11):1737-1748. PubMed ID: 34369622
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.
Lewis R; Maurer HC; Singh N; Gonzalez-Menendez I; Wirth M; Schick M; Zhang L; Isaakidis K; Scherger AK; Schulze V; Lu J; Zenz T; Steiger K; Rad R; Quintanilla-Martinez L; Espeli M; Balabanian K; Keller U; Habringer S
Leukemia; 2021 Oct; 35(10):2895-2905. PubMed ID: 34363012
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of Laboratory and Clinical Feature in the Patients with Myeloproliferative Neoplasm Co-expression of BCR-ABL1 and JAK2 V617F].
Yuan XG; Wan RT; Zhao XW; Yang XZ; Xiao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1236-1241. PubMed ID: 34362508
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of Clinical Characteristics of JAK2 V617F and BCR-ABL Double-Mutant Myeloproliferative Neoplasms].
Yan J; Ding YW; Wang PY; Wu YP; Zhang HC; Liu LH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1540-1547. PubMed ID: 34627437
[TBL] [Abstract][Full Text] [Related]
19. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.
Soderquist CR; Ewalt MD; Czuchlewski DR; Geyer JT; Rogers HJ; Hsi ED; Wang SA; Bueso-Ramos CE; Orazi A; Arber DA; Hexner EO; Babushok DV; Bagg A
Mod Pathol; 2018 May; 31(5):690-704. PubMed ID: 29327708
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]